FDA Approves Expanded Indication for Leqvio : vimarsana.com

Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not had a cardiovascular event but are at an increased risk of heart

Related Keywords

United States , Americans , Victor Bulto , Drug Administration , Expert Panel On Detection , Novartis Pharmaceuticals Corp , Novartis , Centers For Disease , World Health Organization , Novartis Innovative Medicines , East Hanover , High Blood Cholesterol , Executive Summary , Third Report , National Cholesterol Education Program , Expert Panel , Adult Treatment Panel , Disease Control , Health Organization , Primary Prevention , Cardiovascular Disease , American College , American Heart Association Task Force , Clinical Practice , Vital Signs , Heart Attacks ,